APA

van Royen N., Piek J. J., Legemate D. A., Schaper W., Oskam J., Atasever B., Voskuil M., Ubbink D., Schirmer S. H., Buschmann I., Bode C. & Buschmann E. E. (20040511). Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. : Vascular medicine (London, England).

Chicago

van Royen Niels, Piek Jan J, Legemate Dink A, Schaper Wolfgang, Oskam Jacques, Atasever Bektas, Voskuil Michiel, Ubbink Dirk, Schirmer Stephan H, Buschmann Ivo, Bode Christoph and Buschmann Eva E. 20040511. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. : Vascular medicine (London, England).

Harvard

van Royen N., Piek J. J., Legemate D. A., Schaper W., Oskam J., Atasever B., Voskuil M., Ubbink D., Schirmer S. H., Buschmann I., Bode C. and Buschmann E. E. (20040511). Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. : Vascular medicine (London, England).

MLA

van Royen Niels, Piek Jan J, Legemate Dink A, Schaper Wolfgang, Oskam Jacques, Atasever Bektas, Voskuil Michiel, Ubbink Dirk, Schirmer Stephan H, Buschmann Ivo, Bode Christoph and Buschmann Eva E. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. : Vascular medicine (London, England). 20040511.